BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28844099)

  • 21. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
    Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas.
    Jin J; You H; Yu B; Deng Y; Tang N; Yao G; Shu H; Yang S; Qin W
    Biochem Biophys Res Commun; 2009 Jan; 379(1):86-91. PubMed ID: 19100240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW; Lee JM; Chan PC; Ng IO
    Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma.
    Zhang L; Jia G; Shi B; Ge G; Duan H; Yang Y
    Cell Physiol Biochem; 2016; 40(3-4):757-769. PubMed ID: 27915333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
    Qin CD; Ma DN; Zhang SZ; Zhang N; Ren ZG; Zhu XD; Jia QA; Chai ZT; Wang CH; Sun HC; Tang ZY
    Cell Death Dis; 2018 May; 9(5):486. PubMed ID: 29706627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
    Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
    Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
    Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
    Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
    Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH
    Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
    Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
    Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.